Glymab Therapeutics Limited

Biotechnology company · Oxford, England, United Kingdom

Glymab Therapeutics Limited is a biotechnology company headquartered in Oxford, England, United Kingdom. Its earliest recorded incorporation is in 2025. It is registered with UK Companies House under company number 16538942.

Profile compiled from public records. Is this your company? Request a correction or update

Glymab Therapeutics at a glance

Typebiotechnology company

HeadquartersOxford, England, United Kingdom

Earliest incorporation on record2025

Registered activities (UK)Research and experimental development on biotechnology

UK company number16538942

Frequently asked questions about Glymab Therapeutics

Where is Glymab Therapeutics headquartered?

Glymab Therapeutics Limited is headquartered in Oxford, England, United Kingdom.

What does Glymab Therapeutics do?

Glymab Therapeutics Limited is a biotechnology company.

When was Glymab Therapeutics founded?

The earliest incorporation on record for Glymab Therapeutics Limited is in 2025, according to public company registers.

Similar companies

Blue Earth Diagnostics LimitedOxford, England, United Kingdom
Circassia IncOxford, England, United Kingdom
Scancell LimitedOxford, England, United Kingdom
Genomics LimitedOxford, England, United Kingdom
Oxford Biotherapeutics LtdOxford, England, United Kingdom
Sitryx Therapeutics LimitedOxford, England, United Kingdom
Spybiotech LimitedOxford, England, United Kingdom
Omass Therapeutics LimitedOxford, England, United Kingdom

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences